跳至主要内容
临床试验/ISRCTN10530863
ISRCTN10530863已完成不适用

Hyaluronic acid and chondroitin sulphate (Ialuril soft gel ® HA 20 mg, CS 200 mg, curcuma longa 200 mg, quercetina 200 mg) versus placebo in the prevention of urinary infections in female patients with multiple sclerosis: a single centre, randomized, placebo-controlled, double-blind trial

The Second University of Naples (Seconda Università degli studi di Napoli)0 个研究点目标入组 60 人开始时间: 2015年4月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 2. Age >18years
  • 3. Diagnosis of MS according to the McDonald Revised criteria
  • 4. Expanded Disability Status Scale less < 8
  • 5. Documented history of recurrent cystitis defined as at least three episodes of uncomplicated infection documented by urine culture with the isolation of >10000 CFU/ml of an identified pathogen in the last year with clinical symptoms

排除标准

  • 1. Age >80 years
  • 2. UTIs in the previous year < 3
  • 3. Concomitant UTI at the beginning of the study or ongoing prophylactic antibiotic treatment
  • 4. Known neoplasia, urinary stone or abnormality of the urinary tract
  • 5. Chronic kidney disease, diabetes mellitus, use of spermicides or intrauterine devices

研究者

发起方
The Second University of Naples (Seconda Università degli studi di Napoli)

相似试验